The chemosensitivity of 23 human head and neck squamous cell carcinomas (9 pharyngeal , 5 laryngeal, 5 oral cavity, 2 maxillary sinus, 1 salivary gland, 1 cervical esophagus) were examined using subrenal capsule (SRC) assays against 5-FU, FT, UFT and HCFU . Assays adequate for evaluation were obtained in 19 of 23 cases and the averages of tumor size changes on day 6 were , 17.3% for control, -0.8% for 5-FU, 10.3% for FT, -10 .4% for UFT and 2.4% for HCFU.
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Sensitivity rates for each drug were 26.3% for 5-FU, 6.3% for FT, 38.9% for UFT and 11.1% for HCFU.
To evaluate the clinical utility of these anticancer drugs, we determined the therapeutic index (TI), the ratio between tumor chemosensitivity and changes in animal body weight as a criterion for toxicity. 
